Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biovance 3L Ocular
- Development stage
- Unknown
- Lead developer
- Celularity
- Administration
- Ophthalmic
01
Overview
Biovance 3L Ocular is a three-layer decellularized, dehydrated, human amniotic membrane biologic medical device. Developed by Celularity and distributed exclusively in the United States by Verséa Ophthalmics, it is designed as a biological membrane covering that provides an extracellular matrix (ECM) to support the healing of advanced ocular surface diseases. The allograft consists of three layers of amniotic membrane that act as a barrier to protect underlying tissue and preserve tissue plane boundaries. It is indicated for various ocular conditions, including corneal epithelial defects, pterygium repair, and fornix reconstruction, and can be applied either surgically or topically to the ocular surface. The product is regulated by the FDA as a human tissue-based product under Section 361 of the Public Health Service Act.
- Brand names
- Biovance 3L OcularBiovance3L OcularBiovance-3L OcularBiovance
- Other names
- Biovance 3LBiovance3LBiovance-3L
Beyond the preview
Go deeper on Biovance 3L Ocular.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biovance 3L Ocular.